TGTX

TG THERAPEUTICS, INC.

Biotechnology · Biotechnology

$279.59 sample

+0.32 (+0.11%) 1D

Market cap

$1.07T

Price as of

2026-10-04

Latest filing

8-K · 2026-09-28

Alerts

8

Price$279.59 +1.62% 3M daily closessample

279.59261.90

2026-07-072026-07-292026-08-202026-09-102026-10-02

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Sep 28SECForm 144 filed
Sep 23SEC10-Q filed
Sep 14SECForm 144 filed
Sep 07INSInsider sell: 10% owner
Aug 31INSInsider buy: Chief Financial Officer
Aug 21INSInsider sell: 10% owner
Aug 17INSInsider sell: General Counsel
Aug 06INSInsider sell: Chief Executive Officer

Sign up to see the real TGTX record →

Company facts

SEC EDGAR registration

Name: TG THERAPEUTICS, INC.
Sector: Biotechnology
Industry: Biotechnology
Smart-money score: -35sample, -100 to +100
Reporting currency: USD

Who is positioning in TGTX

sample

Insiders: 23 insider transactions over 90 days, net selling, $433.9M
Congress: 2 members traded over 90 days
Institutions · 13F: 34 funds hold $12.9B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$48.6B +16.6% y/y

Q4 2024Q3 2026

Inventory$28.9B +15.1% y/y

Q4 2024Q3 2026

Accounts receivable$22.6B +22.3% y/y

Q4 2024Q3 2026

Total debt$57.1B +12.6% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $597.7B +13.7% 3M
Sample peer B: $261.5B -4.0% 3M
Sample peer C: $231.8B +1.8% 3M
Sample peer D: $400.3B -8.9% 3M
Sample peer E: $632.8B +6.2% 3M